Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherReceivables RefundsShares Repurchased
Ratios

Indivior Pharmaceuticals (INDV) Receivables - Other (2023 - 2025)

Indivior Pharmaceuticals (INDV) has 3 years of Receivables - Other data on record, last reported at $2.0 million in Q4 2025.

  • For Q4 2025, Receivables - Other changed 0.0% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, changed 0.0%, while the annual FY2025 figure was $2.0 million, 0.0% changed from the prior year.
  • Receivables - Other reached $2.0 million in Q4 2025 per INDV's latest filing, roughly flat from $2.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $2.0 million in Q4 2024 and bottomed at $1.0 million in Q4 2023.
  • Average Receivables - Other over 3 years is $1.7 million, with a median of $2.0 million recorded in 2024.
  • Peak YoY movement for Receivables - Other: surged 100.0% in 2024, then changed 0.0% in 2025.
  • A 3-year view of Receivables - Other shows it stood at $1.0 million in 2023, then soared by 100.0% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Other were $2.0 million in Q4 2025, $2.0 million in Q4 2024, and $1.0 million in Q4 2023.